Macular oedema remains the main cause of vision loss in these patients, and intravitreal corticosteroid therapy is essential when anti-vascular endothelial growth factor (VEGF) response is inadequate, or the disease recurs [1]. The gene discussed is VEGFA; the disease is macular retinal edema.